Navigation Links
Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
Date:4/28/2008

NANJING, China, April 28 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced its participation in Credit Suisse's 3rd Annual Healthcare Trip, to be held May 6-10 and May 19-25 in Shenzhen, Shanghai, Beijing and Weihai.

Simcere senior management will give a presentation at the Grand Hyatt Shanghai on Wednesday, May 7, 2008, from 10:10 a.m. to 11:10 a.m. Beijing/Hong Kong time.

A copy of Simcere's investor presentation will be available on the investor relations portion of the Company's Web site, located at http://www.simcere.com.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has focused its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introduced a first-to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke management medication, and is the exclusive distributor of
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
2. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
3. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... A mechanised blue dye test alte...ackaging quality assurance one step closer for pha...t leak testing machine developed by Sepha for ...talled in several local and global pharma-companie...ss quality assurance and productivity improvements...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech ...irus, genomic data from the 1918 pandemic through ...ent H1N1 pandemic, today issued its latest biochem...t the lethality of the H1N1 ("Swine Flu") virus ha...he virus,s current outbreak in the spring of 2009 ...
(Date:11/25/2009)..., MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochroma...hD to its Board of Directors. Dr. Moldt will repla...on the Company,s Board. The number of Board member...very pleased to welcome Peter Moldt to the board a...and guidance as Cytochroma continues to make progr...
(Date:11/25/2009)..., SAN DIEGO, Nov. 25 ... today that Barry D. Quart, Pharm.D., president an...er Jaffray 21st Annual Health Care Conference. , ,...ay 21st Annual Health Care Conference,Date: T...ern Time,Location: The New York Palace Hotel, New...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... CHICAGO Early this year, the ongoing saga of the...those of you who havent been following the news ov...ile bid by French pharmaceutical giant Sanofi-Syn... giant Aventis . , ,This would create a real maj...bined company would create the worlds third-larges...
... Madison, Wis. -- Pulling an all-nighter has never...sconsin-Madison Business School students who won...s Lang, Gail McGuire and Paul Pucci, all MBA stude...nture capitalists and a $100 cash prize. , ,The ne...ing, is designed to put students in the role of ve...
... Madison, Wis. -- Third Wave Technologies Inc , a...announced the release of its Invader 2D6 analysis ...with access to a broad range of pharmacogenetic as...panel is a pharmacogenetic testing solution that o...onfigure custom assay panels. The panel is being u...
Other Biology Technology:The Industry Impact of Two Big Pharmas Mating 2The Industry Impact of Two Big Pharmas Mating 3The Industry Impact of Two Big Pharmas Mating 4The Industry Impact of Two Big Pharmas Mating 5The Industry Impact of Two Big Pharmas Mating 6The Industry Impact of Two Big Pharmas Mating 7VC Contest Winners Learn from Experience 2Third Wave Releases Gene Test 2
(Date:11/26/2009)...hitehead researchers have developed a new type of ...c genes and proteins used by pathogens, according ...l cultures genes are present in two copies: one in...ene inactivation by mutation is therefore ineffici...nd copy usually remains active and takes over. , ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ach, may be used to boost resistance to, or slow, ...l of Medicine researchers report in a study publis...nce . , Parkinson,s disease is caused by a degen...rain known as the substantia nigra, which is respo...n of dopamine in late-stage Parkinson,s causes sym...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2Scientist Throws Curve Into Breaking Ball Debate 60403 1Scientist Throws Curve Into Breaking Ball Debate 60403 2Scientist Throws Curve Into Breaking Ball Debate 60403 3Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 1Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 2Anesiva Announces Date for 2009 Annual Meeting of Stockholders to Vote on Proposed Merger 60400 3
...der, CO, USA - BULLETIN papers examine carbon-14...ests high ice-sheet sensitivity to small climate c...ied fossil forest in the Gold Hill Loess, Alaska; ... shrimp affect groundwater flow in the Biscayne aq... Appalachian Basin; and banded iron formations exp...
...rn microscopy technology has allowed two scorpion ...ity in Berlin and Lorenzo Prendini of the American...what is nearly invisible. Looking at tiny morpholo... outgrowths on lamellaestructures that fold like t...ory system its name, the book lungKamenz and Prend...
...SON, WI, JANUARY 12, 2009 - With recent increase i...nto alternative energy sources, the increased harv...ion is likely in the future. This may be especiall... in part because perennially high residue amounts ...ue left on the soil surface is a source of inoculu...
Other Biology News:January-February GSA Bulletin media highlights 2January-February GSA Bulletin media highlights 3January-February GSA Bulletin media highlights 4January-February GSA Bulletin media highlights 5January-February GSA Bulletin media highlights 6January-February GSA Bulletin media highlights 7January-February GSA Bulletin media highlights 8January-February GSA Bulletin media highlights 9January-February GSA Bulletin media highlights 10January-February GSA Bulletin media highlights 11Microscopic morphology adds to the scorpion family tree 2Microscopic morphology adds to the scorpion family tree 3Preventing soil erosion in continuous corn 2
...High pH, Concentrated x 10 This pH 9.9 solution i... to immunohistochemical staining procedures. It is...ue sections mounted on glass slides. For particula...specially effective. It should be noted that also ...
L-Selenomethionine from Calbiochem
...verts any scanner into a gel densitometer. Althoug..., the basic operation simply consists of convertin... density / intensity values through a few simple s...ensitometer. Automatically digitize lanes and seg...
BioLogic Maximizer Mixer from Bio-Rad
Biology Products: